Advertisement

Topics

Ensemble Therapeutics Corporation Company Profile

16:42 EDT 20th September 2018 | BioPortfolio

Based in Cambridge, MA, Ensemble Therapeutics is deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Ensemble is leveraging its macrocycle drug discovery expertise to fuel its proprietary drug candidate pipeline while also pursuing collaborations with pharmaceutical partners. Ensemble has established high-value partnerships including alliances with Bristol-Myers Squibb and Pfizer. Ensemble’s internal discovery and development efforts are focused on the key therapeutic areas of oncology and immuno-inflammatory diseases, with its lead program, a small molecule antagonist of Interleukin-17, a cytokine implicated in multiple inflammatory and autoimmune diseases, poised to enter development with an orally active candidate by the end of 2012. For more information, visit: www.ensembletx.com.


News Articles [827 Associated News Articles listed on BioPortfolio]

Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers

Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partne...

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the...

Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orio...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Sirpa Jalkanen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Sirpa Jalkanen Orion Corporation has received the ...

High-performance virtual screening by targeting a high-resolution RNA dynamic ensemble

Orion Corporation: Managers' transactions - Heikki Westerlund

ORION CORPORATION      MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Heikki Westerlund Orion Co...

PubMed Articles [583 Associated PubMed Articles listed on BioPortfolio]

HLPI-Ensemble: Prediction of human lncRNA-protein interactions based on ensemble strategy.

LncRNA plays an important role in many biological and disease progression by binding to related proteins. However, the experimental methods for studying lncRNA-protein interactions are time-consuming ...

Supramolecularly Engineered Circular Bivalent Aptamer for Enhanced Functional Protein Delivery.

Circular bivalent aptamers (cb-apt) comprise an emerging class of chemically engineered aptamers with substantially improved stability and molecular recognition ability. Its therapeutic application, h...

Challenges in Visual Analysis of Ensembles.

Modeling physical phenomena through computational simulation increasingly relies on generating a collection of related runs, known as an ensemble. This article explores the challenges we face in devel...

Novel forecasting approaches using combination of machine learning and statistical models for flood susceptibility mapping.

In this research, eight individual machine learning and statistical models are implemented and compared, and based on their results, seven ensemble models for flood susceptibility assessment are intro...

Attentional modulation of hierarchical ensemble coding for the identities of moving faces.

Observers can accurately compute summary statistics from a set of similar objects, which is referred to as ensemble coding. Few studies have investigated whether ensemble coding can be modulated by at...

Clinical Trials [158 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1439 Associated Companies listed on BioPortfolio]

Ensemble Therapeutics Corporation

Based in Cambridge, MA, Ensemble Therapeutics is deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Ensemble i...

Ensemble Discovery Corporation

Based in Cambridge, MA, Ensemble Discovery Corporation is deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. E...

ArtusLabs, Inc.

ArtusLabs is a business intelligence and document management company focused on providing Web 2.0 enabled software solutions to life science organizations. Its flagship product, E...

Ensemble Therapeutics

EnsemblinsTM are a new class of synthetic macrocycles developed by Ensemble using its proprietary chemistry platforms, including DNA-Programmed ChemistryTM. Macrocyc...

Wellstat Therapeutics Corporation

Wellstat Therapeutics™ Corporation is a privately-held biopharmaceutical company located in Gaithersburg, Maryland. Dedicated to the discovery, development and commercialization of innovative therap...

More Information about "Ensemble Therapeutics Corporation" on BioPortfolio

We have published hundreds of Ensemble Therapeutics Corporation news stories on BioPortfolio along with dozens of Ensemble Therapeutics Corporation Clinical Trials and PubMed Articles about Ensemble Therapeutics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ensemble Therapeutics Corporation Companies in our database. You can also find out about relevant Ensemble Therapeutics Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record